Legal & General Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-61,603
| Closed | -$7.29M | – | 3790 |
|
|
2021
Q1 | $7.29M | Sell |
61,603
-4,153
| -6% | -$491K | ﹤0.01% | 1393 |
|
|
2020
Q4 | $7.77M | Sell |
65,756
-7,015
| -10% | -$815K | ﹤0.01% | 1251 |
|
|
2020
Q3 | $8.09M | Buy |
72,771
+2,032
| +3% | +$218K | ﹤0.01% | 1117 |
|
|
2020
Q2 | $7.23M | Buy |
70,739
+1,485
| +2% | +$159K | ﹤0.01% | 1134 |
|
|
2020
Q1 | $7.47M | Buy |
69,254
+6,795
| +11% | +$781K | ﹤0.01% | 996 |
|
|
2019
Q4 | $7.27M | Buy |
62,459
+1,615
| +3% | +$187K | ﹤0.01% | 1181 |
|
|
2019
Q3 | $6.96M | Buy |
60,844
+58,487
| +2,481% | +$5.82M | ﹤0.01% | 1131 |
|
|
2019
Q2 | $225K | Hold |
2,357
| – | – | ﹤0.01% | 2321 |
|
|
2019
Q1 | $215K | Hold |
2,357
| – | – | ﹤0.01% | 2320 |
|
|
2018
Q4 | $179K | Hold |
2,357
| – | – | ﹤0.01% | 2333 |
|
|
2018
Q3 | $189K | Buy |
2,357
+475
| +25% | +$44.3K | ﹤0.01% | 2344 |
|
|
2018
Q2 | $187K | Sell |
1,882
-1,084
| -37% | -$93.7K | ﹤0.01% | 2313 |
|
|
2018
Q1 | $240K | Hold |
2,966
| – | – | ﹤0.01% | 2262 |
|
|
2017
Q4 | $234K | Hold |
2,966
| – | – | ﹤0.01% | 2267 |
|
|
2017
Q3 | $274K | Buy |
2,966
+865
| +41% | +$83.1K | ﹤0.01% | 2236 |
|
|
2017
Q2 | $238K | Hold |
2,101
| – | – | ﹤0.01% | 2244 |
|
|
2017
Q1 | $210K | Hold |
2,101
| – | – | ﹤0.01% | 2241 |
|
|
2016
Q4 | $226K | Hold |
2,101
| – | – | ﹤0.01% | 2199 |
|
|
2016
Q3 | $262K | Hold |
2,101
| – | – | ﹤0.01% | 1963 |
|
|
2016
Q2 | $223K | Buy |
2,101
+400
| +24% | +$46.5K | ﹤0.01% | 1734 |
|
|
2016
Q1 | $195K | Buy |
1,701
+800
| +89% | +$93.8K | ﹤0.01% | 1750 |
|
|
2015
Q4 | $128K | Buy |
901
+200
| +29% | +$23.1K | ﹤0.01% | 1940 |
|
|
2015
Q3 | $63K | Buy |
+701
| New | +$74K | ﹤0.01% | 2327 |
|
Legal & General Group's CBPO Position: Q2 2021 in Review
Legal & General Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 61,603 shares — an estimated $7.29M sold.
Legal & General Group first reported a position in CBPO in Q3 2015 and held it in 23 quarters. The position peaked at $8.09M in Q3 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Legal & General Group reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Legal & General Group sold 61,603 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $7.29M.
- Legal & General Group first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 23 quarters.
- Legal & General Group's China Biologic Products Holdings, Inc. position peaked at $8.09M in Q3 2020.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.